Global Acne Drugs Market (2021 to 2030)


DUBLIN, 25 November 2021 / PRNewswire / – The “Acne Drugs Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030” the report was added to offer.

At an estimated value of over $ 91.38 billion In 2020, the global acne drugs market is expected to thrive at a CAGR of 3.9% and valued at over $ 14.26 billion over the forecast year 2021-2030.

Acne is the most common skin condition, usually caused by changes in the structures of the skin. It affects nearly millions of adolescents around the world. Hence, there is a huge demand for topical and oral acne medications. Topical medications include creams, gels, and ointments made up of retinoids, benzoyl peroxide, salicylic acid, and others. On the other hand, oral acne medications are relatively more effective when moderate to severe acne does not respond to topical agents.

Market dynamics and trends

Many factors such as changing hormone levels, increasing teenage population, and increasing adoption of skin care products are dramatically driving the growth of the global acne drugs market. In addition, excessive production of oil from sebaceous glands and unhygienic lifestyle cause acne to appear, which has a positive impact on the growth of the market.

However, side effects such as skin irritation, dry skin, and skin erythema or redness due to the use of acne drugs are expected to hamper the growth of the market. On the contrary, increasing R&D in skin care as well as high market potential in untapped emerging countries are expected to be opportunistic for market growth. Additionally, the increasing frequency and severity of acne is one of the major factors that will fuel the market size during the forecast period.

Market segments and scope of the study:

The global acne drugs market share is segmented on the basis of therapeutic class, formulation, type, type of acne, distribution channel and geography. On the basis of therapeutic class, the market is categorized into Retinoids, Antibiotics, Benzoyl Peroxide, Salicylic Acid, and others. Based on formulation, the market is segmented into topical drugs and oral drugs. Based on type, the market is divided into prescription and over-the-counter drugs.

On the basis of acne type, the market is divided into non-inflammatory acne and inflammatory acne. According to the distribution channel, it is classified into retail stores, e-commerce and drugstores and drugstores. The geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and ROW.

Geographic analysis

In terms of geography, North America held a large share of the market in 2019. This is attributed to the increase in the use of skin care products and the increased awareness of natural acne drugs propelled the demand for acne drugs in this region. However, Asia Pacific is expected to grow rapidly with increasing market size due to factors such as increased healthcare spending and increased demand for acne treatments in developing countries in the region.

Competitive landscape

The maximum growth opportunities make the acne drugs market very competitive. Some of the major players in the market are Almirall SA., Bausch Health Companies Inc., Galderma SA, Mayne Pharma Group Limited, GlaxoSmithKline Plc (GSK), Mylan NV, Pfizer Inc., Johnson & Johnson, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd. and many others. A number of development strategies have been adopted by companies in recent years. For example, in june 2020, Bausch Health Companies Inc. and Ortho Dermatologics, announced that ARAZLO (tazarotene) lotion is commercially available for healthcare professionals in the United States. ARAZLO is tazarotene acne treatment medication which is available as a lotion.

Also in February 2020, Almirall, SA (ALM) announced the development of Seysara (sarecycline), the advanced oral antibiotic derived from tetracycline for the treatment of inflammatory lesions of moderate to severe non-nodular acne vulgaris. The product is expected to be submitted to the National Medical Products Administration (NMPA) in 2023.

Main topics covered:

1. Introduction
1.1. Description of the report
1.2. Who should read this report
1.3. Key market segments
1.4. Research methodology

2. Acne Drugs Market – Summary
2.1. Market Snapshot, 2020 – 2030, in USD Million

3. Market overview
3.1. Definition and scope of the market
3.2. Market dynamics

4. Covid-19 analysis
4.1. Impact on market size
4.2. End-user trends and preferences, and budgetary and economic impact
4.3. Strategies of the main players to fight against the influence of Covid-19 on the market

5. Market share analysis
5.1. Major Suppliers of Acne Drugs Market Share Analysis, 2020

6. Global Acne Drugs Market, By Therapeutic Class
6.1. Overview
6.2. Retinoids
6.3. Antibiotics
6.4. Salicylic acid
6.5. Benzoyl peroxide
6.6. Others

7. Global Acne Drugs Market, By Formulation
7.1. Overview
7.2. Topical medications
7.3. Oral medications

8. Global Acne Drugs Market, By Type
8.1. Overview
8.2. Prescription drugs
8.3. Over-the-counter medications

9. Global Acne Drugs Market, By Acne Type
9.1. Overview
9.2. Inflammatory acne
9.3. Non-inflammatory acne

10. Global Acne Drugs Market, By Distribution Channel
10.1. Overview
10.2. Grocery stores
10.3. Pharmacies and pharmacies
10.4. E-commerce

11. Global Acne Drugs Market, By Region
11.1. Overview
11.2. North America
11.3. Europe
11.4. Asia Pacific
11.5. Rest of the world

12. Company profiles
12.1. Almirall SA
12.2. Bausch Health Companies Inc.
12.3. Johnson & johnson
12.4. GlaxoSmithKline plc
12.5. Galderma
12.6. Mayne Pharma Group Limited
12.7. Viatris inc.
12.8. Sun Pharmaceutical Industries Limited
12.9. Pfizer Inc.
12.10. Teva Pharmaceutical Industries Ltd.

For more information on this report, visit

Media contact:

Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1907
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links


Comments are closed.